Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - indapamide hemihydrate, quantity: 2.5 mg - tablet, film coated - excipient ingredients: maize starch; povidone; sodium lauryl sulfate; macrogol 6000; magnesium stearate; white beeswax; glycerol; titanium dioxide; lactose monohydrate; purified talc; hypromellose - natrilix is indicated in the management of essential hypertension. it may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. normally natrilix is used as the initial agent in multiple drug regimens.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (aust) pty ltd - indapamide hemihydrate, quantity: 1.5 mg - tablet, modified release - excipient ingredients: lactose monohydrate; macrogol 6000; hypromellose; magnesium stearate; titanium dioxide; colloidal anhydrous silica; glycerol; povidone - management of essential hypertension. it may be tried as a sole therapeutic agent in the treatment of mild to moderate hypertension. normally, natrilix sr is used as the initial agent in multiple drug regimes.

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - indapamide hemihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - indapamide hemihydrate -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - indapamide - modified-release tablet - 1.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - indapamide - modified-release tablet - 1.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - indapamide - modified-release tablet - 1.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

necessity supplies ltd - indapamide - modified-release tablet - 1.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - indapamide - modified-release tablet - 1.5mg

Singapore - English - HSA (Health Sciences Authority)

servier (s) pte ltd - indapamide - tablet, film coated - 1.5 mg - indapamide 1.5 mg